[1]
M. M. R. Putra and K. P. Seputra, “The Potential of Cammelia sinensis (Tea Leaves) Active Compound as Alternative Therapy on castrate-resistant prostate cancer (CRPC) with Androgen Receptor Inhibition: In Silico Study”, BHSJ, vol. 5, no. 1, pp. 25–28, Apr. 2022.